Target
Cytochrome P450 3A4
Ligand
BDBM50572808
Substrate
n/a
Meas. Tech.
ChEMBL_2118300 (CHEMBL4827366)
IC50
6500±n/a nM
Citation
 Liang, JZbieg, JRBlake, RAChang, JHDaly, SDiPasquale, AGFriedman, LSGelzleichter, TGill, MGiltnane, JMGoodacre, SGuan, JHartman, SJIngalla, ERKategaya, LKiefer, JRKleinheinz, TLabadie, SSLai, TLi, JLiao, JLiu, ZMody, VMcLean, NMetcalfe, CNannini, MAOeh, JO'Rourke, MGOrtwine, DFRan, YRay, NCRoussel, FSambrone, ASampath, DSchutt, LKVinogradova, MWai, JWang, TWertz, IEWhite, JRYeap, SKYoung, AZhang, BZheng, XZhou, WZhong, YWang, X GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer. J Med Chem 64:11841-11856 (2021) [PubMed]  Article 
Target
Name:
Cytochrome P450 3A4
Synonyms:
Albendazole monooxygenase | Albendazole sulfoxidase | CP3A4_HUMAN | CYP3A3 | CYP3A4 | CYPIIIA3 | CYPIIIA4 | Cytochrome P450 3A3 | Cytochrome P450 3A4 (CYP3A4) | Cytochrome P450 HLp | Nifedipine oxidase | Quinine 3-monooxygenase | Taurochenodeoxycholate 6-alpha-hydroxylase
Type:
Enzyme
Mol. Mass.:
57349.57
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
503
Sequence:
MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGA
  
Inhibitor
Name:
BDBM50572808
Synonyms:
Gdc-9545 | Giredestrant | RO-7197597 | RO7197597
Type:
Small organic molecule
Emp. Form.:
C27H31F5N4O
Mol. Mass.:
522.5533
SMILES:
C[C@@H]1Cc2c([nH]c3ccccc23)[C@H](N1CC(F)(F)CO)c1c(F)cc(NC2CN(CCCF)C2)cc1F |r|
Structure:
Search PDB for entries with ligand similarity: